Last reviewed · How we verify
NCT06830902: COMFIJ
Comparison of Stent-Related Symptoms: Regular Double J Stent vs. Comfi J Stent
NA trial testing Regular Double J stent in Stent Related Symptoms in 100 participants. Not yet recruiting.
15 August 2025
Quick facts
| Lead sponsor | Bir Hospital |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 100 |
| Start date | 15 February 2025 |
| Primary completion | 15 August 2025 |
| Estimated completion | 15 September 2025 |
| Sites | 1 location across Nepal |
Drugs / interventions tested
- Regular Double J stent
- Comfi J stent
Conditions studied
- Stent Related Symptoms — all drugs for Stent Related Symptoms →
Sponsor
Bir Hospital
Who can join
Adults 18 to 80, any sex, with Stent Related Symptoms. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A prospective, single-blinded, randomized controlled trial conducted at a single center to compare stent related symptoms between two different stents using Ureteral Stent Symptom Questionnaire (USSQ) scores , Visual Analog Scale (VAS) pain scores.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06830902
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Stent Related Symptoms
Currently open trials in the same condition.
- NCT06966804 — Comparison of Alpha Blockers (Terazosin and Tamsulosin) in Reducing Ureteral Stent Related Symptoms · Phase 3 · recruiting
Other Bir Hospital trials
Trials by the same sponsor.
- NCT06803030 — Study of Tamsulosin, Solifenacin and Mirabegron in Alleviating Ureteral Stent-related Symptoms · Phase 3 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06830902 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Bir Hospital
- Last refreshed: 19 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06830902.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing